- ICH GCP
- US Clinical Trials Registry
- Search trials
Kliniske forsøg sponsoreret af Multiple Myeloma Research Consortium
I alt 32 resultater
-
Multiple Myeloma Research ConsortiumIkke rekrutterer endnuRefraktær Myelom | Tilbagefaldende myelomatose
-
CelgeneMultiple Myeloma Research ConsortiumAfsluttet
-
Massachusetts General HospitalMultiple Myeloma Research ConsortiumAktiv, ikke rekrutterendeMyelomatoseForenede Stater
-
Astex Pharmaceuticals, Inc.Multiple Myeloma Research ConsortiumAfsluttetMyelomatoseForenede Stater
-
University Health Network, TorontoMultiple Myeloma Research ConsortiumAfsluttetMyelomatose | Tilbagefaldende/IldfastCanada
-
Multiple Myeloma Research FoundationAfsluttet
-
Multiple Myeloma Research FoundationAktiv, ikke rekrutterende
-
Emory UniversitySynta Pharmaceuticals Corp.; Multiple Myeloma Research ConsortiumAfsluttetMyelomatoseForenede Stater
-
AmgenMultiple Myeloma Research FoundationGodkendt til markedsføring
-
University Health Network, TorontoAstellas Pharma Inc; Multiple Myeloma Research ConsortiumAfsluttetMyelomatoseForenede Stater, Canada
-
Massachusetts General HospitalBristol-Myers Squibb; Celgene; Multiple Myeloma Research ConsortiumAktiv, ikke rekrutterendeMyelomatoseForenede Stater
-
Mayo ClinicMultiple Myeloma Research FoundationAfsluttetTilbagevendende plasmacellemyelom | t(11;14)Forenede Stater
-
Washington University School of MedicineMillennium Pharmaceuticals, Inc.; Multiple Myeloma Research ConsortiumAktiv, ikke rekrutterende
-
Wake Forest University Health SciencesIncyte Corporation; Amgen; Multiple Myeloma Research ConsortiumAfsluttetMyelomatoseForenede Stater
-
Massachusetts General HospitalNovartis; Barbara Ann Karmanos Cancer Institute; Multiple Myeloma Research...RekrutteringMyelomatoseForenede Stater
-
Dana-Farber Cancer InstituteBristol-Myers Squibb; Multiple Myeloma Research Consortium; Blood Cancer...AfsluttetUlmende myelomatoseForenede Stater
-
Barbara Ann Karmanos Cancer InstituteBristol-Myers Squibb; Janssen Pharmaceuticals; Multiple Myeloma Research...Rekruttering
-
Icahn School of Medicine at Mount SinaiBristol-Myers Squibb; Multiple Myeloma Research ConsortiumTilmelding efter invitation
-
Barbara Ann Karmanos Cancer InstituteBristol-Myers Squibb; National Cancer Institute (NCI); Multiple Myeloma Research...Aktiv, ikke rekrutterendeTilbagevendende primær amyloidoseForenede Stater
-
Dana-Farber Cancer InstituteJanssen Pharmaceuticals; The Leukemia and Lymphoma Society; Multiple Myeloma... og andre samarbejdspartnereAktiv, ikke rekrutterendeUlmende myelomatose | Monoklonal gammopatiForenede Stater
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH); Millennium... og andre samarbejdspartnereAktiv, ikke rekrutterendeRefraktært plasmacellemyelom | Tilbagevendende plasmacellemyelomForenede Stater
-
University of ChicagoNational Cancer Institute (NCI); Multiple Myeloma Research FoundationRekrutteringMyelomatoseForenede Stater, Canada
-
University of ChicagoNational Cancer Institute (NCI); Multiple Myeloma Research FoundationAktiv, ikke rekrutterendePlasmacellemyelom | Resterende sygdomForenede Stater
-
University of California, San FranciscoJanssen Pharmaceuticals; Multiple Myeloma Research FoundationAfsluttetRefraktært plasmacellemyelom | Tilbagevendende plasmacellemyelomForenede Stater
-
University of ChicagoBristol-Myers Squibb; Amgen; Multiple Myeloma Research FoundationAktiv, ikke rekrutterendeMyelomatoseForenede Stater
-
Dana-Farber Cancer InstituteBristol-Myers Squibb; Celgene; The Leukemia and Lymphoma Society; Multiple... og andre samarbejdspartnereAfsluttetE-PRISM: Fase II-forsøg med Elotuzumab Lenalidomid og Dexamethason ved højrisiko-ulmende myelomatoseUlmende myelomatose | Ulmende myelomForenede Stater
-
Emory UniversityNovartis; University of Chicago; University of California, San Francisco; A... og andre samarbejdspartnereAfsluttet
-
Multiple Myeloma Research FoundationSpectrum Health Hospitals; Translational Genomics Research Institute; Van...AfsluttetMyelomatoseForenede Stater, Spanien, Canada
-
Multiple Myeloma Research ConsortiumEli Lilly and Company; GlaxoSmithKline; AbbVie; Takeda; Genentech, Inc.; Celgene... og andre samarbejdspartnereRekrutteringRecidiverende refraktært myelomatoseForenede Stater
-
Ludwig Institute for Cancer ResearchCancer Research Institute, New York City; MedImmune LLC; Multiple Myeloma...AfsluttetMyelomatoseForenede Stater
-
University of Heidelberg Medical CenterJanssen Research & Development, LLC; Deutsche Studiengruppe Multiples Myelom...Rekruttering
-
Multiple Myeloma Research ConsortiumBristol-Myers Squibb; Memorial Sloan Kettering Cancer Center; Washington... og andre samarbejdspartnereAktiv, ikke rekrutterendeMyelomatose | Recidiverende refraktært myelomatoseForenede Stater